Created in partnership with the Physicians Coalition for Injectable Safety, Black Market Cosmetic Injectables in the U. S. 2005 – 2013 highlights the pervasive intrusion of fake and misbranded injectable cosmetic treatments into the secure U.S. drug supply chain.
Since 2005, there has been one death and 11 other patients who required medical attention for disfigurement or serious illness as the result of receiving fake or misbranded cosmetic injectables while at a doctor’s office, clinic, or salon. Black Market Cosmetic Injectables in the U.S. 2005-2013 attempts to describe the scope of the problem.
There have been 46 individuals in 16 states who have faced prosecution for their alleged purchase or sale of non-FDA approved cosmetic drugs with a whole variety of substances being passed off as Botox, collagen or other injected cosmetic treatments.
In 2012, the FDA notified 350 medical practices in 43 states that they may have purchased counterfeit Botox and since then more than 700 doctors across all therapeutic areas have received letters warning them that they may have purchased non-FDA approved drugs.
Find out how fake and misbranded injectable cosmetic treatments have become one of the most common ways patients are exposed to counterfeits. Download and share Black Market Cosmetic Injectables in the U.S. 2005-2013.